Product Information
RANOLAZINE ER 500 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.1629 per EA under NDC 72319002102. Its NADAC has been published 187 times since Nov 30, 2022.
Strength
500 mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319002102
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RANOLAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA213517On Market Since
6/15/2022
Pharmacological Classes
Price Statistics
The NADAC for RANOLAZINE ER 500 MG TABLET has been published 187 times since Nov 30, 2022, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1629 per EA |
|---|---|
| All-time high | $0.2647 (Jan 10, 2024) |
| All-time low | $0.1624 (Feb 18, 2026) |
| 52-week high | $0.1976 |
| 52-week low | $0.1624 |
| Median price | $0.2106 |
| Average price | $0.2072 |
| Largest weekly change | +17.6% (Aug 21, 2024) |
| Weeks tracked | 187 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RANOLAZINE ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.1629 per EA (NDC 72319002102), effective Jun 24, 2026.
How has the price of RANOLAZINE ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 35.6%. It has been tracked across 187 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?
Since Nov 30, 2022, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1624 (Feb 18, 2026) to a high of $0.2647 (Jan 10, 2024), with a median of $0.2106 per EA.
Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as RANOLAZINE ER 500 MG TABLET, but none are currently priced below it.
Who manufactures RANOLAZINE ER 500 MG TABLET?
RANOLAZINE ER 500 MG TABLET (NDC 72319002102) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification